Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
BRCA2突变细胞的致癌机制
基本信息
- 批准号:6399060
- 负责人:
- 金额:$ 30.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-06-01 至 2002-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The BRCA2 gene is a cancer predisposition gene, which is matured in breast cancer, prostate cancer, ovarian cancer, esophageal cancer , and pancreatic cancer. In response to the critique, we have markedly modified this proposal to study mouse BRCA2 defective cells (BRCA2--) instead of human BRCA2 defective Vance cells, since the genetic defect in the mouse cells is simpler. Our preliminary data in mouse BRCA2-- cells shows that Rad51 is rapidly cleaved by caspase-3 in BRCA2 defective cells and that overexpression of BRCA2 or Rad51, or inhibition of caspase-3 reverse radioactivity and the DNA repair defect. A caspase-3 resistant Rad51 mutant (D- A187Rad51) reverses radio sensitivity and the DNA repair in brca2-- to a greater extent than wildtype Rad51 when both proteins are expressed at near physiologic levels. We have recently purified Rad51 and caspase-3 proteins to allow in vitro mechanistic studies. We present new data showing Rad51 is mostly cytoplasmic in brca2--, and that wildtype BRCA2 expression relocates Rad51 to the nucleus whereas mutant BRCA2 expression does not effect Rad51 localization. These fundings lead to the following hypotheses: 1. BRCA2 normally functions in double strand DNA break repair; 2. BRCA2 and Rda51 function in the same biochemical pathway mediating DNA repair; 3. BRCA2 stabilizes Rad51 by inhabiting degradation by caspase-3 and other proteases; 4. BRCA2 influences nuclear localization of Rad51. To test hypothesis we propose these aims. Aim 1: Determine the functional domains of BRCA2 protein which mediate double strand break repair and tumorigenesis. Aim 2: See if known additional mutations in BRCA2 defective cancer cells contribute to radiation sensitivity & DNA repair defects in brca2-- cells. Aim 3: Determine the mechanism and in vivo significance off BRCA2- Rad51 interactions by in vitro assays. Aim 4: Analyze mechanism of BRCA2- Rad51 localization. Aim 5: Develop and use in Vivo imaging methods to study Rad51 localization and DNA repair in living cells, in real time.
BRCA 2基因是一种癌症易感基因,在乳腺癌、前列腺癌、卵巢癌、食道癌和胰腺癌中成熟。作为对这一批评的回应,我们对这一提议进行了显著修改,以研究小鼠BRCA 2缺陷细胞(BRCA 2-)而不是人类BRCA 2缺陷万斯细胞,因为小鼠细胞中的遗传缺陷更简单。我们在小鼠BRCA 2--细胞中的初步数据显示,在BRCA 2缺陷细胞中,Rad 51被caspase-3快速切割,并且BRCA 2或Rad 51的过表达或caspase-3的抑制逆转放射性和DNA修复缺陷。抗半胱天冬酶-3的Rad 51突变体(D-A187 Rad 51)逆转放射敏感性和brca 2中的DNA修复--当两种蛋白质均以接近生理水平表达时,其逆转程度大于野生型Rad 51。我们最近纯化了Rad 51和caspase-3蛋白,以进行体外机制研究。我们目前的新数据显示,Rad 51主要是在brca 2细胞质-,野生型BRCA 2表达重新定位Rad 51的细胞核,而突变体BRCA 2表达不影响Rad 51的本地化。这些发现导致了以下假设:1。BRCA 2通常在双链DNA断裂修复中发挥作用; 2. BRCA 2和Rda 51在介导DNA修复的相同生化途径中起作用; 3. BRCA 2通过抑制caspase-3和其他蛋白酶的降解来稳定Rad 51; 4. BRCA 2影响Rad 51的核定位。为了检验假设,我们提出了这些目标。目的1:确定BRCA 2蛋白介导双链断裂修复和肿瘤发生的功能域。目的2:了解BRCA 2缺陷癌细胞中已知的其他突变是否有助于BRCA 2-细胞中的辐射敏感性和DNA修复缺陷。目的3:通过体外试验确定BRCA 2-Rad 51相互作用的机制和体内意义。目的4:分析BRCA 2-Rad 51的定位机制。目的5:开发和使用体内成像方法来研究Rad 51在活细胞中的定位和DNA修复,在真实的时间。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey T Holt其他文献
Jeffrey T Holt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey T Holt', 18)}}的其他基金
IHC Test for BRCA1 Hereditary Ovarian Cancer
BRCA1 遗传性卵巢癌的 IHC 检测
- 批准号:
8239640 - 财政年份:2010
- 资助金额:
$ 30.15万 - 项目类别:
IHC Test for BRCA1 Hereditary Ovarian Cancer
BRCA1 遗传性卵巢癌的 IHC 检测
- 批准号:
8259213 - 财政年份:2010
- 资助金额:
$ 30.15万 - 项目类别:
IHC Test for BRCA1 Hereditary Ovarian Cancer
BRCA1 遗传性卵巢癌的 IHC 检测
- 批准号:
7804771 - 财政年份:2010
- 资助金额:
$ 30.15万 - 项目类别:
PARP Inhibitor Targeted Therapy for Breast Cancer
PARP抑制剂靶向治疗乳腺癌
- 批准号:
7481522 - 财政年份:2008
- 资助金额:
$ 30.15万 - 项目类别:
Development of a BRCA Breast Cancer Diagnostic Test
BRCA 乳腺癌诊断测试的开发
- 批准号:
7325640 - 财政年份:2007
- 资助金额:
$ 30.15万 - 项目类别:
BRCA2 Hereditary Ovarian Cancer Tissue Truncation Test
BRCA2 遗传性卵巢癌组织截断试验
- 批准号:
7404496 - 财政年份:2007
- 资助金额:
$ 30.15万 - 项目类别:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
BRCA2突变细胞的致癌机制
- 批准号:
6559526 - 财政年份:2001
- 资助金额:
$ 30.15万 - 项目类别:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
BRCA2突变细胞的致癌机制
- 批准号:
6514387 - 财政年份:2001
- 资助金额:
$ 30.15万 - 项目类别:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
BRCA2突变细胞的致癌机制
- 批准号:
6608872 - 财政年份:2001
- 资助金额:
$ 30.15万 - 项目类别:
Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
BRCA2突变细胞的致癌机制
- 批准号:
6913605 - 财政年份:2001
- 资助金额:
$ 30.15万 - 项目类别:
相似海外基金
Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
- 批准号:
22K09003 - 财政年份:2022
- 资助金额:
$ 30.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
- 批准号:
21K07762 - 财政年份:2021
- 资助金额:
$ 30.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
- 批准号:
20K16927 - 财政年份:2020
- 资助金额:
$ 30.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
- 批准号:
20H00526 - 财政年份:2020
- 资助金额:
$ 30.15万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
- 批准号:
20K21245 - 财政年份:2020
- 资助金额:
$ 30.15万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
- 批准号:
G0900887/1 - 财政年份:2011
- 资助金额:
$ 30.15万 - 项目类别:
Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
- 批准号:
05558090 - 财政年份:1993
- 资助金额:
$ 30.15万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
- 批准号:
04453031 - 财政年份:1992
- 资助金额:
$ 30.15万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)